One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Immune Checkpoint Combos in Metastatic Castration-Resistant Prostate Cancer: Where Are We Going, What Are We Doing, and Why?.
doi : 10.1200/JCO-24-02402
Volume 43(14) pgs. 1617-1749 May 10, 2025
They Not Like Us: Evaluating the Diverse Strategies in Locally Advanced Rectal Cancer Treatment.
doi : 10.1200/JCO-24-02178
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.
doi : 10.1200/JCO-24-01673
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.
doi : 10.1200/JCO-24-01283
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.
doi : 10.1200/JCO-24-01675
Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer.
doi : 10.1200/JCO.24.00405
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study.
doi : 10.1200/JCO-24-02407
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.
doi : 10.1200/JCO-24-02219
Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.
doi : 10.1200/JCO-24-01933
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.
doi : 10.1200/JCO-24-01334
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.
doi : 10.1200/JCO-25-00099
Risks of Organ Preservation in Rectal Cancer: Beyond Distant Metastases, Ultimate Local Failure Can Also Be a Problem.
doi : 10.1200/JCO-24-02518
Distant Metastases With Nonoperative Management in Rectal Cancer: Challenges in Defining Risk.
doi : 10.1200/JCO-24-02714
Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear.
doi : 10.1200/JCO-24-02723
Reply to: "Risks of Organ Preservation in Rectal Cancer: Beyond Distant Metastases, Ultimate Local Failure Can Also Be a Problem," "Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear," and "Distant Metastases With Nonoperative Management in Rectal Cancer: Challenges in Defining Risk".
doi : 10.1200/JCO-25-00132
Erratum: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.
doi : 10.1200/JCO-25-00722
